free light chains kappa lambda
Selected indexed studies
- The Use of Kappa Free Light Chains to Diagnose Multiple Sclerosis. (Medicina (Kaunas), 2022) [PMID:36363469]
- The role of free kappa and lambda light chains in the pathogenesis and treatment of inflammatory diseases. (Biomed Pharmacother, 2017) [PMID:28494417]
- κ and λ urine free light chains: a new method for quantification. (Tumori, 2020) [PMID:31955649]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- The Use of Kappa Free Light Chains to Diagnose Multiple Sclerosis. (2022) pubmed
- The role of free kappa and lambda light chains in the pathogenesis and treatment of inflammatory diseases. (2017) pubmed
- κ and λ urine free light chains: a new method for quantification. (2020) pubmed
- Relevance of Kappa and Lambda Free Light Chains in Autoimmune Astrocytopathy Associated With Anti-GFAP Antibodies. (2025) pubmed
- Serum free light chains among twin siblings: is the kappa/lambda ratio genetically determined? (2024) pubmed
- Serum Free Light Chain Assay: Shift Toward a Higher κ/λ Ratio. (2020) pubmed
- Clinical specificity of two assays for immunoglobulin kappa and lambda free light chains. (2024) pubmed
- Concentrations of Serum Free Light Chains in Kappa and Lambda Lesions in Light-Chain Myelomas. (2019) pubmed
- Free light chains: Eclectic multipurpose biomarker. (2017) pubmed
- Intrathecal kappa free light chains as markers for multiple sclerosis. (2020) pubmed